The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy

Frontiers in Immunology

Volumn 5, Issue MAY, 2014, Pages

  Khoury, Maroun ^a,b,c   Alcayaga Miranda, Francisca ^a,b   Illanes, Sebastián E ^a   Figueroa, Fernando E ^a  

^a UNIVERSIDAD DE LOS ANDES   (Chile)

^b Chilean Consortium for Regenerative Medicine   (Chile)

^c Consortium in Tissue Engineering ^*  (Chile)

Author keywords

Cell therapy; Menstrual blood; Menstrual stem cells; Mesenchymal stem cells; Stem cells

Indexed keywords

GAMMA INTERFERON RECEPTOR; TELOMERASE REVERSE TRANSCRIPTASE; TUMOR NECROSIS FACTOR;

ALLOTRANSPLANTATION; ANGIOGENESIS ASSAY; BACTERIAL GROWTH; CELL PROLIFERATION; CELL THERAPY; ENDOMETRIUM; ENVIRONMENTAL FACTOR; HOSPITALIZATION; HUMAN; IMMUNOMODULATION; IMMUNOPHENOTYPING; LAMINA PROPRIA; MENSTRUAL CYCLE; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PLURIPOTENT STEM CELL; PRENATAL DIAGNOSIS; PROTEIN EXPRESSION; REGENERATIVE MEDICINE; REVIEW;

EID: 84987818356     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00205     Document Type: Review

References (65)

1. Meng X, Ichim TE, Zhong J, Rogers A, Yin Z, Jackson J, et al. Endometrial regenerative cells: a novel stem cell population. J Transl Med (2007) 5:57. doi: 10.1186/1479-5876-5-57
2. Gargett CE, Chan RW, Schwab KE. Endometrial stem cells. Curr Opin Obstet Gynecol (2007) 19:377-83. doi:10.1097/GCO.0b013e328235a5c6
3. Lee JB, Lee JE, Park JH, Kim SJ, Kim MK, Roh SI, et al. Establishment and maintenance of human embryonic stem cell lines on human feeder cells derived from uterine endometrium under serum-free condition. Biol Reprod (2005) 72:42-9. doi:10.1095/biolreprod.104.033480
4. Patel AN, Park E, Kuzman M, Benetti F, Silva FJ, Allickson JG. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant (2008) 17:303-11. doi:10.3727/096368908784153922
5. Patel AN, Silva F. Menstrual blood stromal cells: the potential for regenerative medicine. Regen Med (2008) 3:443-4. doi:10.2217/17460751.3.4.443
6. Mabuchi Y, Houlihan DD, Akazawa C, Okano H, Matsuzaki Y. Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers. Stem Cells Int (2013) 2013:507301. doi:10.1155/2013/507301
7. Allickson J, Xiang C. Human adult stem cells from menstrual blood and endometrial tissue. J Zhejiang Univ Sci B (2012) 13:419-20. doi:10.1631/jzus.B1200062
8. Allickson JG, Sanchez A, Yefimenko N, Borlongan CV, Sanberg PR. Recent studies assessing the proliferative capability of a novel adult stem cell identified in menstrual blood. Open Stem Cell J (2011) 3:4-10. doi:10.2174/1876893801103010004
9. Cui CH, Uyama T, Miyado K, Terai M, Kyo S, Kiyono T, et al. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation. Mol Biol Cell (2007) 18:1586-94. doi:10.1091/mbc.E06-09-0872
10. Mou XZ, Lin J, Chen JY, Li YF, Wu XX, Xiang BY, et al. Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells. J Zhejiang Univ Sci B (2013) 14:961-72. doi:10.1631/jzus.B1300081
11. Borlongan CV, Kaneko Y, Maki M, Yu SJ, Ali M, Allickson JG, et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev (2010) 19:439-52. doi:10.1089/scd.2009.0340
12. Khanjani S, Khanmohammadi M, Zarnani AH, Akhondi MM, Ahani A, Ghaempanah Z, et al. Comparative evaluation of differentiation potential of menstrual blood-versus bone marrow-derived stem cells into hepatocyte-like cells. PLoS One (2014) 9:e86075. doi:10.1371/journal.pone.0086075
13. Hida N, Nishiyama N, Miyoshi S, Kira S, Segawa K, Uyama T, et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. Stem Cells (2008) 26:1695-704. doi:10.1634/stemcells.2007-0826
14. Rahimi M, Mohseni-Kouchesfehani H, Zarnani AH, Mobini S, Nikoo S, Kazemnejad S. Evaluation of menstrual blood stem cells seeded in biocompatible Bombyx mori silk fibroin scaffold for cardiac tissue engineering. J Biomater Appl (2014). doi:10.1177/0885328213519835
15. Azedi F, Kazemnejad S, Zarnani AH, Behzadi G, Vasei M, Khanmohammadi M, et al. Differentiation potential of menstrual blood-versus bone marrow-stem cells into glial-like cells. Cell Biol Int (2014) 38:615-24. doi:10.1002/cbin.10245
16. Li Y, Li X, Zhao H, Feng R, Zhang X, Tai D, et al. Efficient induction of pluripotent stem cells from menstrual blood. Stem Cells Dev (2013) 22:1147-58. doi:10.1089/scd.2012.0428
17. 8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction. Haematologica (2007) 92:881-8. doi:10.3324/haematol.11240
18. Djouad F, Fritz V, Apparailly F, LOUIS-Plence P, Bony C, Sany J, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum (2005) 52:1595-603. doi:10.1002/art.21012
19. Russell MW, Mestecky J. Tolerance and protection against infection in the genital tract. Immunol Invest (2010) 39:500-25. doi:10.3109/08820131003674834
20. Zhong Z, Patel AN, Ichim TE, Riordan NH, Wang H, Min WP, et al. Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med (2009) 7:15. doi:10.1186/1479-5876-7-15
21. Murphy MP, Wang H, Patel AN, Kambhampati S, Angle N, Chan K, et al. Allogeneic endometrial regenerative cells: an "Off the shelf solution" for critical limb ischemia? J Transl Med (2008) 6:45. doi:10.1186/1479-5876-6-45
22. Nikoo S, Ebtekar M, JEDDI-Tehrani M, Shervin A, Bozorgmehr M, Kazemnejad S, et al. Effect of menstrual blood-derived stromal stem cells on proliferative capacity of peripheral blood mononuclear cells in allogeneic mixed lymphocyte reaction. J Obstet Gynaecol Res (2012) 38:804-9. doi:10.1111/j.1447-0756.2011.01800.x
23. Majumdar MK, KEANE-Moore M, Buyaner D, Hardy WB, Moorman MA, Mcintosh KR, et al. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci (2003) 10:228-41. doi:10.1007/BF02256058
24. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood (2005) 105:1815-22. doi:10.1182/blood-2004-04-1559
25. Polchert D, Sobinsky J, Douglas G, Kidd M, Moadsiri A, Reina E, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol (2008) 38:1745-55. doi:10.1002/eji.200738129
26. Ren C, Kumar S, Chanda D, Chen J, Mountz JD, Ponnazhagan S. Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells (2008) 26:2332-8. doi:10.1634/stemcells.2008-0084
27. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell (2008) 2:141-50. doi:10.1016/j.stem.2007.11.014
28. Meisel R, Brockers S, Heseler K, Degistirici O, Bulle H, Woite C, et al. Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase. Leukemia (2011) 25:648-54. doi:10.1038/leu.2010.310
29. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther (2012) 20:14-20. doi:10.1038/mt.2011.211
30. Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum (2009) 60:1006-19. doi:10.1002/art.24405
31. Sun L, Akiyama K, Zhang H, Yamaza T, Hou Y, Zhao S, et al. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells (2009) 27:1421-32. doi:10.1002/stem.68
32. Youd M, Blickarz C, Woodworth L, Touzjian T, Edling A, Tedstone J, et al. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin Exp Immunol (2010) 161:176-86. doi:10.1111/j.1365-2249.2010.04158.x
33. 4+ T cell activation. Immunol Lett (2011) 135:10-6. doi:10.1016/j.imlet.2010.09.006
34. 17 molecular program through the PD-1 pathway. PLoS One (2012) 7:e45272. doi:10.1371/journal.pone.0045272
35. 17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum (2009) 60:1472-83. doi:10.1002/art.24499
36. Torrente D, Avila M, Cabezas R, Morales L, Gonzalez J, Samudio I, et al. Paracrine factors of human mesenchymal stem cells increase wound closure and reduce reactive oxygen species production in a traumatic brain injury in vitro model. Hum Exp Toxicol (2013). doi:10.1177/0960327113509659
37. Figueroa FE, Carrion F, Villanueva S, Khoury M. Mesenchymal stem cell treatment for autoimmune diseases: a critical review. Biol Res (2012) 45:269-77. doi:10.4067/S0716-97602012000300008
38. Li J, Huang S, Wu Y, Gu C, Gao D, Feng C, et al. Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome. Int Wound J (2014) 11(2):114-21. doi:10.1111/iwj.12202
39. Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, et al. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev (2013) 65:336-41. doi:10.1016/j.addr.2012.07.001
40. Miranda KC, Bond DT, Mckee M, Skog J, Paunescu TG, DA Silva N, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int (2010) 78:191-9. doi:10.1038/ki.2010.106
41. Skog J, Wurdinger T, Van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol (2008) 10:1470-6. doi:10.1038/ncb1800
42. Zhou Y, Xu H, Xu W, Wang B, Wu H, Tao Y, et al. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther (2013) 4:34. doi:10.1186/scrt194
43. Lin R, Wang S, Zhao RC. Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model. Mol Cell Biochem (2013) 383:13-20. doi:10.1007/s11010-013-1746-z
44. Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, et al. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett (2012) 315:28-37. doi:10.1016/j.canlet.2011.10.002
45. Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, et al. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev (2012) 21:3289-97. doi:10.1089/scd.2012.0095
46. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells (2010) 28:2229-38. doi:10.1002/stem.544
47. Wu X, Luo Y, Chen J, Pan R, Xiang B, Du X, et al. Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice. Stem Cells Dev (2014). doi:10.1089/scd.2013.0390
48. Rossignoli F, Caselli A, Grisendi G, Piccinno S, Burns JS, Murgia A, et al. Isolation, characterization, and transduction of endometrial decidual tissue multipotent mesenchymal stromal/stem cells from menstrual blood. Biomed Res Int (2013) 2013:901821. doi:10.1155/2013/901821
49. Han X, Meng X, Yin Z, Rogers A, Zhong J, Rillema P, et al. Inhibition of intracranial glioma growth by endometrial regenerative cells. Cell Cycle (2009) 8:606-10. doi:10.4161/cc.8.4.7731
50. Bockeria L, Bogin V, Bockeria O, Le T, Alekyan B, Woods EJ, et al. Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic. J Transl Med (2013) 11:56. doi:10.1186/1479-5876-11-56
51. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ (2007) 335:974. doi:10.1136/bmj.39335.385301.BE
52. Berks D, Hoedjes M, Raat H, Duvekot JJ, Steegers EA, Habbema JD. Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study. BJOG (2013) 120:924-31. doi:10.1111/1471-0528.12191
53. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J (2008) 156:918-30. doi:10.1016/j.ahj.2008.06.042
54. Kadyrov M, Kingdom JC, Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol (2006) 194:557-63. doi:10.1016/j.ajog.2005.07.035
55. Borzychowski AM, Croy BA, Chan WL, Redman CW, Sargent IL. Changes in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cells. Eur J Immunol (2005) 35:3054-63. doi:10.1002/eji.200425929
56. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science (2005) 308:1592-4. doi:10.1126/science.1111726
57. Redman CW, Sargent IL. Microparticles and immunomodulation in pregnancy and pre-eclampsia. J Reprod Immunol (2007) 76:61-7. doi:10.1016/j.jri.2007.03.008
58. Vives A, Balasch J, Yague J, Quinto L, Ordi J, Vanrell JA. Type-1 and type-2 cytokines in human decidual tissue and trophoblasts from normal and abnormal pregnancies detected by reverse transcriptase polymerase chain reaction (RT-PCR). Am J Reprod Immunol (1999) 42:361-8. doi:10.1111/j.1600-0897.1999.tb00113.x
59. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta (2008) 29(Suppl A):S73-7. doi:10.1016/j.placenta.2007.11.016
60. Sabapatha A, GERCEL-Taylor C, Taylor DD. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol (2006) 56:345-55. doi:10.1111/j.1600-0897.2006.00435.x
61. Luo SS, Ishibashi O, Ishikawa G, Ishikawa T, Katayama A, Mishima T, et al. Human villous trophoblasts express and secrete placenta-specific microRNAs into maternal circulation via exosomes. Biol Reprod (2009) 81:717-29. doi:10.1095/biolreprod.108.075481
62. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res (2010) 4:214-22. doi:10.1016/j.scr.2009.12.003
63. Lai RC, Yeo RW, Tan KH, Lim SK. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation. Regen Med (2013) 8:197-209. doi:10.2217/rme.13.4
64. Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol (2012) 3:359. doi:10.3389/fphys.2012.00359
65. van Koppen A, Joles JA, Van Balkom BW, Lim SK, DE Kleijn D, Giles RH, et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease. PLoS One (2012) 7:e38746. doi:10.1371/journal.pone.0038746